← Assessments

A21-136·Sofosbuvir/ velpatasvir/ voxilaprevir·Immune system and infections

Initial/ Published 2022-01-17

Abstract

Sofosbuvir/ velpatasvir/ voxilaprevir for Genotype 1, 4, 5 or 6. IQWiG concluded benefit not proven.

Source

Source markdown is not available for this project.